Breast Cancer, Younger Women
It’s a sobering statistic: 1 in 8 women in the United States will be diagnosed with breast cancer during her lifetime.1 ...
Morgan Pressel's 18th annual Morgan & Friends event raised a record $1,022,000 to support the fight against breast cancer.
The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of ...
Danielle Fishel is sharing an update about her health, saying she has completed “active cancer treatment” following her ...
Breast cancer detection in its early stages significantly improves survival rates, according to medical experts. While ...
Virginia G. Kaklamani, MD, DSc, discusses findings from the phase 3 TROPION-Breast01 trial of datopotamab deruxtecan.
As cancer treatment costs have increased, identifying and treating early-stage cancer sooner reduces expenses and improves ...
Technology could soon do more than assist doctors. Thanks to advancements in cancer-identifying AI, it could actively save ...
As supported by data from the phase 3 TROPION-Breast01 trial, datopotamab deruxtecan is now an FDA-approved treatment for ...
Datroway has been approved for unresectable or metastatic HR+, HER2- breast cancer after endocrine therapy and chemotherapy.
Annual cancer statistics report identifies persistent racial and ethnic disparities and increases in certain cancers in women ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback